BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21314871)

  • 1. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
    Gaynor P; McCarberg B; Zheng W; Shoemaker S; Duenas H
    Int J Clin Pract; 2011 Mar; 65(3):341-9. PubMed ID: 21314871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
    Perahia DG; Pritchett YL; Desaiah D; Raskin J
    Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall JA; Risser RC; Gonzales JS
    Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
    Crucitti A; Zhang Q; Nilsson M; Brecht S; Yang CR; Wernicke J
    Curr Med Res Opin; 2010 Nov; 26(11):2579-88. PubMed ID: 20874076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.
    Hudson JI; Wohlreich MM; Kajdasz DK; Mallinckrodt CH; Watkin JG; Martynov OV
    Hum Psychopharmacol; 2005 Jul; 20(5):327-41. PubMed ID: 15912562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.
    Pergolizzi JV; Raffa RB; Taylor R; Rodriguez G; Nalamachu S; Langley P
    Pain Pract; 2013 Mar; 13(3):239-52. PubMed ID: 22716295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
    Hall JA; Wang F; Oakes TM; Utterback BG; Crucitti A; Acharya N
    Expert Opin Drug Saf; 2010 Jul; 9(4):525-37. PubMed ID: 20465525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
    Mease PJ; Russell IJ; Kajdasz DK; Wiltse CG; Detke MJ; Wohlreich MM; Walker DJ; Chappell AS
    Semin Arthritis Rheum; 2010 Jun; 39(6):454-64. PubMed ID: 19152958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
    Gahimer J; Wernicke J; Yalcin I; Ossanna MJ; Wulster-Radcliffe M; Viktrup L
    Curr Med Res Opin; 2007 Jan; 23(1):175-84. PubMed ID: 17257478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
    Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
    J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain response profile of patients with fibromyalgia treated with duloxetine.
    Bradley LA; Wohlreich MM; Wang F; Gaynor PJ; Robinson MJ; D'Souza DN; Mease PJ
    Clin J Pain; 2010; 26(6):498-504. PubMed ID: 20551724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
    Skljarevski V; Desaiah D; Zhang Q; Chappell AS; Detke MJ; Gross JL; Ziegler D
    Diabetes Metab Res Rev; 2009 Oct; 25(7):623-31. PubMed ID: 19637208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
    Chappell AS; Littlejohn G; Kajdasz DK; Scheinberg M; D'Souza DN; Moldofsky H
    Clin J Pain; 2009 Jun; 25(5):365-75. PubMed ID: 19454869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
    Skljarevski V; Zhang S; Chappell AS; Walker DJ; Murray I; Backonja M
    Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.